HGUE-C-1 is an atypical and novel colon carcinoma cell line


Colorectal carcinoma is a common cause of cancer. Adjuvant treatments include: 5-fluorouracil administered together with folinic acid, or more recently, oral fluoropyrimidines such as capecitabine, in combination with oxaliplatin or irinotecan. Metastatic colorectal cancer patients can benefit from other additional treatments such as cetuximab or… (More)
DOI: 10.1186/s12885-015-1183-3


10 Figures and Tables

Cite this paper

@inproceedings{Grasso2015HGUEC1IA, title={HGUE-C-1 is an atypical and novel colon carcinoma cell line}, author={Silvina Grasso and Isabel Mart{\'i}nez-Lacaci and V{\'i}ctor Manuel Barber{\'a} and Adela Castillejo and Jos{\'e} Lu{\'i}s Soto and Javier Gallego-Plazas and Natividad L{\'o}pez-Riquelme and Pilar Garc{\'i}a-Morales and Trinidad Mata-Balaguer and Jos{\'e} Antonio Ferragut and Miguel Saceda}, booktitle={BMC Cancer}, year={2015} }